Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Haleon PLC Sponsored ADR HLN

Healthcare  —  Drug Manufacturers Specialty & Generic
9.26 0.04 0.43% as of 25 Sep
Market cap
$40.3B
P/E
20.6×
Cash Flow Champion (3y) Revenue Champion (3y)
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Haleon PLC Sponsored ADR (HLN) Business Profile

Updated before January 2025

Company Overview

Haleon PLC Sponsored ADR (HLN) is a global leader in consumer health, specializing in the development, manufacturing, and marketing of health and wellness products. The company was officially launched in July 2022 as a spin-off from GlaxoSmithKline (GSK), marking its independence as a standalone entity focused exclusively on consumer healthcare. Headquartered in Weybridge, United Kingdom, Haleon operates in over 100 countries, serving millions of consumers worldwide. The company is led by CEO Brian McNamara, who brings extensive experience in the consumer health sector, and a seasoned executive team committed to driving innovation and growth.

Core Business Segments

Haleon’s portfolio is organized into several core business segments, each addressing specific consumer health needs. These segments include:

1. Oral Health

Haleon is a market leader in oral health, offering a range of products designed to improve dental hygiene and overall oral care. Key brands include:

  • Sensodyne: A leading toothpaste brand for sensitive teeth.
  • Parodontax: Specializing in gum health and bleeding gums.
  • Polident: Denture care products, including cleansers and adhesives.

2. Pain Relief

The company provides a variety of over-the-counter (OTC) pain relief solutions. Notable products include:

  • Advil: A globally recognized ibuprofen-based pain reliever.
  • Voltaren: A topical gel for joint and muscle pain.
  • Panadol: A paracetamol-based pain reliever popular in many markets.

3. Respiratory Health

Haleon offers products to address respiratory issues such as colds, allergies, and sinus problems. Key brands include:

  • Theraflu: Cold and flu relief medications.
  • Otrivin: Nasal decongestants and sprays.
  • Flonase: Allergy relief nasal sprays.

4. Digestive Health and Other Wellness Products

This segment includes products aimed at improving digestive health and overall wellness. Key offerings include:

  • Tums: Antacids for heartburn and indigestion relief.
  • Benefiber: Fiber supplements for digestive health.
  • Emergen-C: Vitamin C supplements for immune support.

5. Vitamins, Minerals, and Supplements (VMS)

Haleon also provides a range of VMS products to support general health and wellness. Key brands include:

  • Centrum: Multivitamins for adults and children.
  • Caltrate: Calcium supplements for bone health.

Business Model

Haleon operates a consumer-centric business model that integrates product innovation, marketing, and distribution to generate revenue. The company focuses on:

  • Research and Development (R&D): Investing in science-backed innovations to create effective and trusted health solutions.
  • Brand Building: Leveraging strong brand equity to maintain consumer loyalty and expand market share.
  • Global Distribution: Utilizing a robust supply chain and partnerships with retailers, pharmacies, and e-commerce platforms to ensure product availability worldwide.
  • Sustainability: Incorporating sustainable practices in product development and packaging to meet consumer expectations and regulatory requirements.

Revenue is primarily generated through the sale of OTC health products, with a diversified portfolio that reduces dependence on any single category or market.

Strategic Direction

Haleon’s strategic priorities focus on growth, innovation, and sustainability. Key initiatives include:

  • Expanding Product Portfolio: Developing new products and entering adjacent categories to meet evolving consumer needs.
  • Digital Transformation: Enhancing digital marketing and e-commerce capabilities to reach more consumers.
  • Sustainability Goals: Committing to environmentally friendly practices, such as reducing plastic usage and achieving carbon neutrality by 2040.
  • Geographic Expansion: Strengthening presence in emerging markets, particularly in Asia and Latin America, where demand for consumer health products is growing.

Competitive Landscape

Haleon operates in a highly competitive market, facing competition from both multinational corporations and regional players. Key competitors include:

  • Procter & Gamble (P&G): Competes in oral health and OTC categories with brands like Crest and Vicks.
  • Johnson & Johnson (J&J): Offers a wide range of consumer health products, including Tylenol and Listerine.
  • Reckitt Benckiser: Known for brands like Nurofen, Strepsils, and Gaviscon.
  • Bayer AG: Competes in pain relief and VMS with brands like Aspirin and One A Day.
  • Sanofi: Offers OTC products and supplements, including Allegra and Dulcolax.

Risk Factors

Haleon faces several risks that could impact its operations and financial performance:

  • Market Dependence: Reliance on OTC product sales makes the company vulnerable to changes in consumer preferences and regulatory policies.
  • Supply Chain Disruptions: Global supply chain challenges, including raw material shortages and transportation delays, could affect product availability.
  • Competitive Pressure: Intense competition may lead to pricing pressures and reduced market share.
  • Regulatory Risks: Compliance with health and safety regulations across multiple jurisdictions is complex and costly.
  • Economic Conditions: Economic downturns could reduce consumer spending on non-essential health products.

Recent Developments

Haleon has made significant strides in innovation and corporate strategy since its launch. Recent highlights include:

  • Product Launches: Introduction of new variants of Sensodyne and Voltaren to cater to specific consumer needs.
  • Sustainability Initiatives: Transitioning to recyclable packaging for key products and reducing carbon emissions across operations.
  • Digital Investments: Enhancing e-commerce platforms and launching targeted digital marketing campaigns to boost online sales.
  • Global Events: The COVID-19 pandemic has increased demand for health and wellness products, benefiting Haleon’s portfolio.

Investment Considerations

Strengths:

  • Strong Brand Portfolio: Trusted brands with high consumer loyalty.
  • Global Presence: Extensive geographic reach and diversified revenue streams.
  • Innovation-Driven: Commitment to R&D and product development.
  • Sustainability Focus: Alignment with consumer preferences for eco-friendly products.

Risks:

  • Market Volatility: Dependence on consumer spending and economic conditions.
  • Regulatory Challenges: Compliance costs and potential legal issues.
  • Competitive Landscape: Pressure from established and emerging players.

Conclusion

Haleon PLC Sponsored ADR is well-positioned as a leader in the consumer health sector, with a robust portfolio of trusted brands and a clear focus on innovation and sustainability. While the company faces challenges such as competitive pressures and supply chain risks, its strategic initiatives and global presence provide a strong foundation for future growth. Investors seeking exposure to the growing consumer health market may find Haleon an attractive option, given its strengths and commitment to long-term value creation.